| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967154 | Vaccine | 2014 | 7 Pages |
Abstract
A delayed third dose at 12 months is immunologically non-inferior and superior for four HPV virus types. Using an alternate dosing schedule offers more flexibility to receive the 3-dose HPV vaccine and may result in higher vaccination rates among college-age males.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Chyongchiou Jeng Lin, Richard K. Zimmerman, Mary Patricia Nowalk, Hsin-Hui Huang, Jonathan M. Raviotta,